z-logo
open-access-imgOpen Access
Should We Utilize Maintenance Therapy Post-Hematopoietic Cell Transplantation in Patients With FLT3/ITD-positive AML?
Author(s) -
Amy E. DeZern
Publication year - 2019
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v16.4.9638
Subject(s) - hematopoietic cell , maintenance therapy , hematopoietic stem cell transplantation , haematopoiesis , medicine , oncology , transplantation , stem cell , biology , chemotherapy , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here